Tourmaline Bio Inc. logo

Tourmaline Bio Inc.

TRML | NASDAQ
Chart Builder DCF Calculator
$47.98
$0 (0.00%)
At close: Oct 28, 2025, 4:00 PM ET

Market Data

Market Cap
$1.23B
Enterprise Value
$993.56M
Beta
1.58
Average Volume
N/A
Shares Outstanding (Diluted)
25.76M
Shares Change YoY
0.12%
Institutional Ownership
93.44%
Exchange
N/A
ISIN
N/A

Price Performance

Price Change 1M
N/A
Price Change 3M
N/A
Price Change 6M
N/A
Price Change YTD
N/A
Price Change 1Y
N/A
Price Change 3Y
N/A
Price Change 5Y
N/A
1M CAGR (ann.)
0.6%
1Y CAGR (ann.)
74.8%
5Y CAGR (ann.)
N/A
All-Time CAGR
-8.7%

Valuation

PE Ratio
-13.99
Forward PE
N/A
PEG Ratio
0.78
Forward PEG
-1.79
PS Ratio
30,816.28
Forward PS
74.00
PB Ratio
4.76
P/FCF Ratio
-14.28
P/Adj. FCF Ratio
-13.05
P/OCF Ratio
-29.44
EV/Sales
24,839.05
EV/EBIT
-10.71
EV/EBITDA
-9.70
EV/FCF
-11.51
Earnings Yield
-7.2%
FCF Yield
-7.0%
Adj. FCF Yield
-7.7%

Financial Health

Net Cash
$239.09M
Total Debt
$145K
Cash & Short-Term Investments
$239.23M
Total Assets
$269.3M
Current Ratio
24.68
Quick Ratio
24.68
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
-595.01
Interest Coverage
0.00
Altman Z-Score
72.19
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
-256122.5%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
-215752.5%
Adj. FCF Margin
-236140.0%
SBC / Revenue
0.0%
SBC Impact (per share)
-9.4%

Returns

Return on Assets
-17.1%
Return on Equity
-17.1%
Return on Invested Capital
-20.1%
Return on Capital Employed
-20.1%
Return on Tangible Assets
-17.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
2.6%
Revenue CAGR 5Y
50.9%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-35.3%
EPS CAGR 5Y
61.1%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-52.0%
FCF CAGR 5Y
-19.7%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
10
EPS Growth Next 3Y
-10.7%
Revenue Growth Next 3Y
1044.3%
Earnings Date
Nov 5, 2025
EPS Estimate (next Q)
-$0.96
EPS Growth Est (next Q)
23.1%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$48.50
Price Target Upside
1.1%

Cash Flow

Operating Cash Flow
$-86.28M
Free Cash Flow
$-86.3M
Adj. Free Cash Flow
$-94.46M
FCF Per Share
-$1.63
OCF Per Share
-$1.63
OCF/S Ratio
0.0%

Income Statement

Revenue
$40K
Gross Profit
$-2K
Operating Income
$-102.45M
EBITDA
$-102.47M
Net Income
$-88.47M
EPS (Diluted)
-$3.43
Revenue / Employee
N/A
Profit / Employee
N/A
Employees
N/A

© 2026 bestshares.com. All rights reserved.